Therapeutic targets & mechanisms for treatment

Dementia and Alzheimer's disease (AD) as of now exhibits one of the greatest medicinal services issues in the created nations. There is no successful treatment equipped for backing off infection movement. As of late the fundamental concentrate of research on novel pharmacotherapies depended on the amyloidogenic speculation of AD, which places that the beta amyloid (Aβ) peptide is primarily in charge of subjective hindrance and neuronal demise. The objective of such medicines is (a) to diminish Aβ creation through the restraint of β and γ secretase chemicals and (b) to advance disintegration of existing cerebral Aβ plaques. Be that as it may, this approach has turned out to be just unobtrusively viable. Late investigations propose an option methodology fixated on the restraint of the downstream Aβ flagging, especially at the neural connection. Aβ oligomers may cause deviant N-methyl-D-aspartate receptor (NMDAR) initiation postsynaptically by shaping buildings with the phone surface prion protein (PrPC). PrPC is enhanced at the neuronal postsynaptic thickness, where it collaborates with Fyn tyrosine kinase. Fyn enactment happens when Aβ is bound to PrPC-Fyn complex. Fyn causes tyrosine phosphorylation of the NR2B subunit of metabotropic glutamate receptor 5 (mGluR5). Fyn kinase blockers masitinib and saracatinib have ended up being effective in treating AD side effects in trial mouse models of the illness.

    Related Conference of Therapeutic targets & mechanisms for treatment

    September 25-26, 2025

    12th Annual congress on Stroke and Neurological Disorders

    Zurich, Switzerland
    October 17-18, 2025

    5th International Conference on Child Neurology

    London, UK
    October 20-21, 2025

    7th World Brain Congress

    Osaka, Japan
    October 23-24, 2025

    8th Global Congress on Spine and Spinal Disorders

    London, UK
    October 27-28, 2025

    36th World Congress on Neurorehabilitation

    Vancouver, Canada
    October 29-30, 2025

    5th Annual Dementia Congress

    Amsterdam, Netherlands
    October 30-31, 2025

    34th Euro Congress on Neurologists and Psychiatrists

    Paris, France
    November 13-14, 2025

    32nd Cognitive Neuroscience Congress

    Bali, Indonesia
    November 24-25, 2025

    37th World Conference on Neurology

    Barcelona, Spain
    November 24-25, 2025

    39th European Neurology Congress

    Barcelona, Spain
    November 27-28, 2025

    13th International Conference on Cannabis & Medicinal Research

    Amsterdam, Netherlands
    December 01-02, 2025

    38th European Neurology Congress 2025

    Vancouver, Canada
    December 04-05, 2025

    17th Global Neurologists Meeting on Neurology and Neurosurgery

    Amsterdam, Netherlands
    December 15-16, 2025

    20th Annual Congress on Neuroscience

    Paris, France
    February 02-03, 2026

    7th Global Summit on Brain Disorders and Therapeutics

    Paris, France
    February 12-13, 2026

    8th World Conference on Neuroscience

    Singapore City, Singapore
    March 09-10, 2026

    7th International Conference on Neurologists

    Singapore City, Singapore
    April 23-24, 2026

    8th World Depression Congress

    Paris, France
    May 14-15, 2026

    9th World Conference on Neuroscience

    Rome, Italy
    May 18-19, 2026

    38th International conference on Mental Health and Psychiatry

    Aix-en-Provence, France
    June 22-23, 2026

    7th World Congress on Sleep Disorders and Therapeutics

    Amsterdam, Netherlands
    June 29-30, 2026

    37th Conference on Clinical Neuroscience and Neurogenetics

    Aix-en-Provence, France

    Therapeutic targets & mechanisms for treatment Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in